U.S. Grants Rare Exception to Cuba Embargo
In a rare exception to long-standing American foreign policy, U.S. officials have approved a small California biotech company's deal with the Cuban government to develop three experimental cancer drugs created in Havana. The agreement announced Thursday by CancerVax Corp. is the first such commercial deal approved by the U.S. government between a U.S. biotechnology company and Cuba, which has spent $1 billion building a biotechnology program that is among the most advanced in the Third World. [more]